| Entry |
|
|---|
| Name |
Insulin, isophane (USP);
Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18);
Isophane insulin (aqueous suspension) (JAN);
Humalog PEN (TN) |
|---|
| Class |
Antidiabetic agent
DG01636 Insulin preparation
DG01802 Human insulin
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidiabetic, Insulin receptor agonist |
|---|
| Target |
INSR (CD220) [HSA:3643] [KO:K04527] |
|---|
| Pathway |
| hsa04910 | Insulin signaling pathway |
|
|---|
| Interaction |
CYP induction: CYP1A2 [HSA:1544]
|
|---|
| Structure map |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01802 Human insulin
D04547 Insulin, isophane
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
D04547 Insulin, isophane
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D04547 Insulin, isophane
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D04547 Insulin, isophane (USP) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D04547 Isophane insulin human (genetical recombination) injectable aqueous suspension
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D04547
|
|---|
| Other DBs |
|
|---|